QURE- Uniqure N.V.

Name: Uniqure N.V. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Uniqure N.V. (QURE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. QURE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Abi-Saab Walid	150.4K	$6.96M	-
Other	Potts Jeannette	133.2K	$6.17M	-5,237
CFO	Klemt Christian	63.9K	$2.96M	-
Dir	Balachandran Madhavan	53.3K	$2.47M	-10,000
Dir	Gut Robert	40.1K	$1.86M	-

Activity

Buys and sells only

Transactions

10 filings · page 20

Date	Insider	Role	Type	Shares	Price	Value	Chg%
May 15, 2019	Kapusta Matthew C64	CEO, CFO, Managing Director	Sell	8,000	$58.38	$467,016.66	-0.6%
Apr 16, 2019	Klemt Christian58	Chief Accounting Officer	Sell	1,546	$57.18	$88,400.28	-2.8%
Apr 1, 2019	Astley-Sparke Philip47	Director	Sell	6,000	$59.84	$359,040.00	-23.7%
Mar 14, 2019	Kapusta Matthew C64	CEO, CFO, Managing Director	Sell	67,376	$63.96	$4,309,296.80	-2.4%
Feb 15, 2019	Kuta Alexander Edward III81	SVP, Regulatory Affairs	Sale+OE	8,000	$35.82	$286,560.00	-9.4%
Jan 28, 2019	Kapusta Matthew C64	CEO, CFO, Managing Director	Sell	19,085	$31.42	$599,650.70	-3.7%
Jan 28, 2019	Van Deventer Sander	Chief Scientific Officer	Sell	1,358	$31.31	$42,518.98	-3.3%
Jan 28, 2019	Klemt Christian58	Chief Accounting Officer	Sell	1,479	$31.29	$46,277.91	-2.6%
Jan 28, 2019	Kuta Alexander Edward III81	SVP, Regulatory Affairs	Sell	1,052	$31.29	$32,917.08	-3.8%
Jan 28, 2019	McMillan Scott T.	Chief Operating Officer	Sell	591	$31.23	$18,456.93	-2.8%

← PrevPage 20Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC